The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Heparin (Low Molecular Weight) Market Research Report 2024
Synopsis
The global Heparin (Low Molecular Weight) market was valued at US$ 338.6 million in 2023 and is anticipated to reach US$ 432.2 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
North American market for Heparin (Low Molecular Weight) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Heparin (Low Molecular Weight) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Heparin (Low Molecular Weight) include Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutical, Changzhou Qianhong Bio-pharma, Techdow and Yantai Dongcheng Pharmaceutical Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Heparin (Low Molecular Weight), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin (Low Molecular Weight).
Report Scope
The Heparin (Low Molecular Weight) market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Heparin (Low Molecular Weight) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heparin (Low Molecular Weight) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group
Segment by Type
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine
Segment by Application
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Heparin (Low Molecular Weight) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Heparin (Low Molecular Weight) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Heparin (Low Molecular Weight) market was valued at US$ 338.6 million in 2023 and is anticipated to reach US$ 432.2 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
North American market for Heparin (Low Molecular Weight) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Heparin (Low Molecular Weight) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Heparin (Low Molecular Weight) include Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutical, Changzhou Qianhong Bio-pharma, Techdow and Yantai Dongcheng Pharmaceutical Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Heparin (Low Molecular Weight), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin (Low Molecular Weight).
Report Scope
The Heparin (Low Molecular Weight) market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Heparin (Low Molecular Weight) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heparin (Low Molecular Weight) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group
Segment by Type
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine
Segment by Application
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Heparin (Low Molecular Weight) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Heparin (Low Molecular Weight) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Heparin (Low Molecular Weight) Market Overview
1.1 Product Overview and Scope of Heparin (Low Molecular Weight)
1.2 Heparin (Low Molecular Weight) Segment by Type
1.2.1 Global Heparin (Low Molecular Weight) Market Value Comparison by Type (2024-2030)
1.2.2 Enoxaparin
1.2.3 Dalteparin
1.2.4 Tinzaparin
1.2.5 Fraxiparine
1.3 Heparin (Low Molecular Weight) Segment by Application
1.3.1 Global Heparin (Low Molecular Weight) Market Value by Application: (2024-2030)
1.3.2 Treatment of Venous Thromboembolism
1.3.3 Complications of Pregnancy
1.3.4 Cardioversion of Atrial Fibrillation/Flutter
1.3.5 Others
1.4 Global Heparin (Low Molecular Weight) Market Size Estimates and Forecasts
1.4.1 Global Heparin (Low Molecular Weight) Revenue 2019-2030
1.4.2 Global Heparin (Low Molecular Weight) Sales 2019-2030
1.4.3 Global Heparin (Low Molecular Weight) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Heparin (Low Molecular Weight) Market Competition by Manufacturers
2.1 Global Heparin (Low Molecular Weight) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Heparin (Low Molecular Weight) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Heparin (Low Molecular Weight) Average Price by Manufacturers (2019-2024)
2.4 Global Heparin (Low Molecular Weight) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Heparin (Low Molecular Weight), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Heparin (Low Molecular Weight), Product Type & Application
2.7 Heparin (Low Molecular Weight) Market Competitive Situation and Trends
2.7.1 Heparin (Low Molecular Weight) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Heparin (Low Molecular Weight) Players Market Share by Revenue
2.7.3 Global Heparin (Low Molecular Weight) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Heparin (Low Molecular Weight) Retrospective Market Scenario by Region
3.1 Global Heparin (Low Molecular Weight) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Heparin (Low Molecular Weight) Global Heparin (Low Molecular Weight) Sales by Region: 2019-2030
3.2.1 Global Heparin (Low Molecular Weight) Sales by Region: 2019-2024
3.2.2 Global Heparin (Low Molecular Weight) Sales by Region: 2025-2030
3.3 Global Heparin (Low Molecular Weight) Global Heparin (Low Molecular Weight) Revenue by Region: 2019-2030
3.3.1 Global Heparin (Low Molecular Weight) Revenue by Region: 2019-2024
3.3.2 Global Heparin (Low Molecular Weight) Revenue by Region: 2025-2030
3.4 North America Heparin (Low Molecular Weight) Market Facts & Figures by Country
3.4.1 North America Heparin (Low Molecular Weight) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Heparin (Low Molecular Weight) Sales by Country (2019-2030)
3.4.3 North America Heparin (Low Molecular Weight) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Heparin (Low Molecular Weight) Market Facts & Figures by Country
3.5.1 Europe Heparin (Low Molecular Weight) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Heparin (Low Molecular Weight) Sales by Country (2019-2030)
3.5.3 Europe Heparin (Low Molecular Weight) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Heparin (Low Molecular Weight) Market Facts & Figures by Country
3.6.1 Asia Pacific Heparin (Low Molecular Weight) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Heparin (Low Molecular Weight) Sales by Country (2019-2030)
3.6.3 Asia Pacific Heparin (Low Molecular Weight) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Heparin (Low Molecular Weight) Market Facts & Figures by Country
3.7.1 Latin America Heparin (Low Molecular Weight) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Heparin (Low Molecular Weight) Sales by Country (2019-2030)
3.7.3 Latin America Heparin (Low Molecular Weight) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Heparin (Low Molecular Weight) Market Facts & Figures by Country
3.8.1 Middle East and Africa Heparin (Low Molecular Weight) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Heparin (Low Molecular Weight) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Heparin (Low Molecular Weight) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Heparin (Low Molecular Weight) Sales by Type (2019-2030)
4.1.1 Global Heparin (Low Molecular Weight) Sales by Type (2019-2024)
4.1.2 Global Heparin (Low Molecular Weight) Sales by Type (2025-2030)
4.1.3 Global Heparin (Low Molecular Weight) Sales Market Share by Type (2019-2030)
4.2 Global Heparin (Low Molecular Weight) Revenue by Type (2019-2030)
4.2.1 Global Heparin (Low Molecular Weight) Revenue by Type (2019-2024)
4.2.2 Global Heparin (Low Molecular Weight) Revenue by Type (2025-2030)
4.2.3 Global Heparin (Low Molecular Weight) Revenue Market Share by Type (2019-2030)
4.3 Global Heparin (Low Molecular Weight) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Heparin (Low Molecular Weight) Sales by Application (2019-2030)
5.1.1 Global Heparin (Low Molecular Weight) Sales by Application (2019-2024)
5.1.2 Global Heparin (Low Molecular Weight) Sales by Application (2025-2030)
5.1.3 Global Heparin (Low Molecular Weight) Sales Market Share by Application (2019-2030)
5.2 Global Heparin (Low Molecular Weight) Revenue by Application (2019-2030)
5.2.1 Global Heparin (Low Molecular Weight) Revenue by Application (2019-2024)
5.2.2 Global Heparin (Low Molecular Weight) Revenue by Application (2025-2030)
5.2.3 Global Heparin (Low Molecular Weight) Revenue Market Share by Application (2019-2030)
5.3 Global Heparin (Low Molecular Weight) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Aspen
6.1.1 Aspen Corporation Information
6.1.2 Aspen Description and Business Overview
6.1.3 Aspen Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Aspen Heparin (Low Molecular Weight) Product Portfolio
6.1.5 Aspen Recent Developments/Updates
6.2 Sanofi-aventis
6.2.1 Sanofi-aventis Corporation Information
6.2.2 Sanofi-aventis Description and Business Overview
6.2.3 Sanofi-aventis Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi-aventis Heparin (Low Molecular Weight) Product Portfolio
6.2.5 Sanofi-aventis Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Heparin (Low Molecular Weight) Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Opocrin
6.4.1 Opocrin Corporation Information
6.4.2 Opocrin Description and Business Overview
6.4.3 Opocrin Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Opocrin Heparin (Low Molecular Weight) Product Portfolio
6.4.5 Opocrin Recent Developments/Updates
6.5 CSBIO
6.5.1 CSBIO Corporation Information
6.5.2 CSBIO Description and Business Overview
6.5.3 CSBIO Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CSBIO Heparin (Low Molecular Weight) Product Portfolio
6.5.5 CSBIO Recent Developments/Updates
6.6 Dongying Tiandong Pharmaceutical
6.6.1 Dongying Tiandong Pharmaceutical Corporation Information
6.6.2 Dongying Tiandong Pharmaceutical Description and Business Overview
6.6.3 Dongying Tiandong Pharmaceutical Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Dongying Tiandong Pharmaceutical Heparin (Low Molecular Weight) Product Portfolio
6.6.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
6.7 Changzhou Qianhong Bio-pharma
6.6.1 Changzhou Qianhong Bio-pharma Corporation Information
6.6.2 Changzhou Qianhong Bio-pharma Description and Business Overview
6.6.3 Changzhou Qianhong Bio-pharma Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Changzhou Qianhong Bio-pharma Heparin (Low Molecular Weight) Product Portfolio
6.7.5 Changzhou Qianhong Bio-pharma Recent Developments/Updates
6.8 Techdow
6.8.1 Techdow Corporation Information
6.8.2 Techdow Description and Business Overview
6.8.3 Techdow Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Techdow Heparin (Low Molecular Weight) Product Portfolio
6.8.5 Techdow Recent Developments/Updates
6.9 Yantai Dongcheng Pharmaceutical Group
6.9.1 Yantai Dongcheng Pharmaceutical Group Corporation Information
6.9.2 Yantai Dongcheng Pharmaceutical Group Description and Business Overview
6.9.3 Yantai Dongcheng Pharmaceutical Group Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Yantai Dongcheng Pharmaceutical Group Heparin (Low Molecular Weight) Product Portfolio
6.9.5 Yantai Dongcheng Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Heparin (Low Molecular Weight) Industry Chain Analysis
7.2 Heparin (Low Molecular Weight) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Heparin (Low Molecular Weight) Production Mode & Process
7.4 Heparin (Low Molecular Weight) Sales and Marketing
7.4.1 Heparin (Low Molecular Weight) Sales Channels
7.4.2 Heparin (Low Molecular Weight) Distributors
7.5 Heparin (Low Molecular Weight) Customers
8 Heparin (Low Molecular Weight) Market Dynamics
8.1 Heparin (Low Molecular Weight) Industry Trends
8.2 Heparin (Low Molecular Weight) Market Drivers
8.3 Heparin (Low Molecular Weight) Market Challenges
8.4 Heparin (Low Molecular Weight) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
